Increased expression of this receptor on AML blasts has been correlated with increased risk of relapse and poor outcome, suggesting that the CXCR4/CXCL12 axis might be involved in immune escape of AML [124–127]. Here, CXCL12 is linked to acute myeloid leukemia.